Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease [Phase 2, Phase 3]

View source ↗

Summary

Pfizer's Phase 2/3 trial of PF-07275315 for chronic obstructive pulmonary disease is currently recruiting, evaluating safety and efficacy in moderate to severe …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• PF-07275315 (PF-07275315)

Snippet

Sponsor: Pfizer | Conditions: Moderate to Severe Chronic Obstructive Pulmonary Disease | Phase 2, Phase 3 | Status: RECRUITING